sulforaphane has been researched along with Cognitive Dysfunction in 6 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (SFN) is a hormetin that activates the antioxidant and anti-inflammatory responses." | 5.72 | Long-term sulforaphane-treatment restores redox homeostasis and prevents cognitive decline in middleaged female and male rats, but cannot revert previous damage in old animals. ( Gómez-González, B; Hernández-Arciga, U; Königsberg, M; Librado-Osorio, R; López-Cervantes, SP; López-Diazguerrero, NE; Luna-López, A; Salas-Venegas, V; Santín-Márquez, R; Toledo-Pérez, R, 2022) |
| " This study aims to test whether sulforaphane (Sfn), a natural activator of nuclear factor erythroid 2-related factor 2 (Nrf2), reduces the chronic ischemic injury and cognitive dysfunction after VCI." | 3.91 | Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway. ( Gao, Y; Lei, X; Li, X; Mao, L; Sun, B; Sun, Y; Yang, T; Zhang, F; Zhang, W; Zhao, Y, 2019) |
| "Sulforaphane (SFN) is a hormetin that activates the antioxidant and anti-inflammatory responses." | 1.72 | Long-term sulforaphane-treatment restores redox homeostasis and prevents cognitive decline in middleaged female and male rats, but cannot revert previous damage in old animals. ( Gómez-González, B; Hernández-Arciga, U; Königsberg, M; Librado-Osorio, R; López-Cervantes, SP; López-Diazguerrero, NE; Luna-López, A; Salas-Venegas, V; Santín-Márquez, R; Toledo-Pérez, R, 2022) |
| "Sulforaphane (SFN) is a pharmacological activator of Nrf2 that provokes Nrf2-mediated intracellular defenses, including antioxidant and anti-inflammatory responses, under oxidative stress (OS) conditions." | 1.48 | Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity. ( Chen, J; Luo, C; Lv, A; Pu, D; Sun, Y; Xiao, Q; Zhao, K; Zhao, Y; Zhu, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Santín-Márquez, R | 1 |
| Hernández-Arciga, U | 1 |
| Salas-Venegas, V | 1 |
| Toledo-Pérez, R | 1 |
| López-Cervantes, SP | 1 |
| Librado-Osorio, R | 1 |
| Luna-López, A | 1 |
| López-Diazguerrero, NE | 1 |
| Gómez-González, B | 1 |
| Königsberg, M | 1 |
| Pauletti, A | 2 |
| Terrone, G | 2 |
| Shekh-Ahmad, T | 2 |
| Salamone, A | 2 |
| Ravizza, T | 2 |
| Rizzi, M | 2 |
| Pastore, A | 2 |
| Pascente, R | 2 |
| Liang, LP | 2 |
| Villa, BR | 2 |
| Balosso, S | 2 |
| Abramov, AY | 2 |
| van Vliet, EA | 2 |
| Del Giudice, E | 2 |
| Aronica, E | 2 |
| Antoine, DJ | 1 |
| Patel, M | 2 |
| Walker, MC | 2 |
| Vezzani, A | 2 |
| Mao, L | 1 |
| Yang, T | 1 |
| Li, X | 1 |
| Lei, X | 1 |
| Sun, Y | 2 |
| Zhao, Y | 2 |
| Zhang, W | 1 |
| Gao, Y | 1 |
| Sun, B | 1 |
| Zhang, F | 1 |
| Pu, D | 1 |
| Chen, J | 1 |
| Lv, A | 1 |
| Zhu, S | 1 |
| Luo, C | 1 |
| Zhao, K | 1 |
| Xiao, Q | 1 |
| Wang, G | 1 |
| Fang, H | 1 |
| Zhen, Y | 1 |
| Xu, G | 1 |
| Tian, J | 1 |
| Zhang, Y | 1 |
| Zhang, D | 1 |
| Zhang, G | 1 |
| Xu, J | 1 |
| Zhang, Z | 1 |
| Qiu, M | 1 |
| Ma, Y | 1 |
| Zhang, H | 1 |
| Zhang, X | 1 |
6 other studies available for sulforaphane and Cognitive Dysfunction
| Article | Year |
|---|---|
Long-term sulforaphane-treatment restores redox homeostasis and prevents cognitive decline in middleaged female and male rats, but cannot revert previous damage in old animals.
Topics: Animals; Antioxidants; Cognitive Dysfunction; Female; Homeostasis; Isothiocyanates; Male; Oxidation- | 2022 |
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.
Topics: Acetylcysteine; Animals; Astrocytes; Biomarkers; Cognitive Dysfunction; Disease Models, Animal; Drug | 2017 |
Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway.
Topics: Animals; Brain; Brain Ischemia; Cell Death; Chronic Disease; Claudin-5; Cognitive Dysfunction; Endot | 2019 |
Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity.
Topics: Alzheimer Disease; Animals; Antioxidants; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Di | 2018 |
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.
Topics: Acetylcysteine; Animals; Astrocytes; Biomarkers; Case-Control Studies; Cell Count; Cognitive Dysfunc | 2019 |
Sulforaphane Prevents Neuronal Apoptosis and Memory Impairment in Diabetic Rats.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Brain-Derived Neurotrophic Factor; Caspase 3; Cognitive | 2016 |